KR20030043471A - 비타민 c 또는 그 유도체 및 빈랑자 추출물을 함유하는피부 노화 방지용 화장료 조성물 - Google Patents
비타민 c 또는 그 유도체 및 빈랑자 추출물을 함유하는피부 노화 방지용 화장료 조성물 Download PDFInfo
- Publication number
- KR20030043471A KR20030043471A KR1020010074658A KR20010074658A KR20030043471A KR 20030043471 A KR20030043471 A KR 20030043471A KR 1020010074658 A KR1020010074658 A KR 1020010074658A KR 20010074658 A KR20010074658 A KR 20010074658A KR 20030043471 A KR20030043471 A KR 20030043471A
- Authority
- KR
- South Korea
- Prior art keywords
- vitamin
- skin
- cosmetic composition
- extract
- skin aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 171
- 239000000203 mixture Substances 0.000 title claims abstract description 84
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 title claims abstract description 81
- 229930003268 Vitamin C Natural products 0.000 title claims abstract description 81
- 239000011718 vitamin C Substances 0.000 title claims abstract description 81
- 235000019154 vitamin C Nutrition 0.000 title claims abstract description 81
- 239000002537 cosmetic Substances 0.000 title claims abstract description 68
- 244000080767 Areca catechu Species 0.000 title claims abstract description 40
- 235000006226 Areca catechu Nutrition 0.000 title claims abstract description 40
- 230000009759 skin aging Effects 0.000 title claims abstract description 22
- 150000003722 vitamin derivatives Chemical class 0.000 title claims description 4
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 claims abstract description 6
- 238000009472 formulation Methods 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 12
- 235000008180 Piper betle Nutrition 0.000 claims description 11
- 240000008154 Piper betle Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 9
- 230000003712 anti-aging effect Effects 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 7
- 239000006210 lotion Substances 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 150000003700 vitamin C derivatives Chemical class 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims description 2
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 2
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 claims description 2
- 229940072107 ascorbate Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 43
- 230000000694 effects Effects 0.000 abstract description 36
- 230000006872 improvement Effects 0.000 abstract description 36
- 102000008186 Collagen Human genes 0.000 abstract description 24
- 108010035532 Collagen Proteins 0.000 abstract description 24
- 229920001436 collagen Polymers 0.000 abstract description 24
- 230000015572 biosynthetic process Effects 0.000 abstract description 18
- 238000003786 synthesis reaction Methods 0.000 abstract description 14
- 230000002401 inhibitory effect Effects 0.000 abstract description 10
- 206010040880 Skin irritation Diseases 0.000 abstract description 8
- 231100000475 skin irritation Toxicity 0.000 abstract description 8
- 230000036556 skin irritation Effects 0.000 abstract description 8
- 102000016387 Pancreatic elastase Human genes 0.000 abstract description 7
- 108010067372 Pancreatic elastase Proteins 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 210000003491 skin Anatomy 0.000 description 68
- 230000000052 comparative effect Effects 0.000 description 31
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 238000012360 testing method Methods 0.000 description 21
- 230000037394 skin elasticity Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 11
- 102000016942 Elastin Human genes 0.000 description 11
- 108010014258 Elastin Proteins 0.000 description 11
- 229920002549 elastin Polymers 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- -1 pack Substances 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 238000002845 discoloration Methods 0.000 description 10
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 229960005070 ascorbic acid Drugs 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 235000013599 spices Nutrition 0.000 description 7
- 230000002195 synergetic effect Effects 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- 230000019612 pigmentation Effects 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- 235000013871 bee wax Nutrition 0.000 description 5
- 239000012166 beeswax Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 5
- 206010014970 Ephelides Diseases 0.000 description 4
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 4
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 4
- 229940113124 polysorbate 60 Drugs 0.000 description 4
- 230000036572 transepidermal water loss Effects 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000007882 cirrhosis Effects 0.000 description 3
- 208000019425 cirrhosis of liver Diseases 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 3
- 229960002591 hydroxyproline Drugs 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- BMZVXYKKNCVBBF-RXSVEWSESA-N NC(=O)NC1NC(=O)NC1=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O Chemical compound NC(=O)NC1NC(=O)NC1=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O BMZVXYKKNCVBBF-RXSVEWSESA-N 0.000 description 2
- 102000004079 Prolyl Hydroxylases Human genes 0.000 description 2
- 108010043005 Prolyl Hydroxylases Proteins 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000180579 Arca Species 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
구 분 | 함량 (중량%) | ||
성 분 | 실시예 | 비교실시예 1 | 비교실시예 2 |
빈랑자 추출물 | 0.03 | - | 0.03 |
비타민 C | 3.0 | 3.0 | - |
부틸렌글리콜 | 2.0 | 2.0 | 2.0 |
프로필렌글리콜 | 6.0 | 6.0 | 2.0 |
카르복시비닐폴리머 | 0.5 | 0.5 | 0.5 |
밀납 | 2.0 | 2.0 | 2.0 |
바셀린 | 7.0 | 7.0 | 7.0 |
폴리솔베이트 60 | 2.0 | 2.0 | 2.0 |
솔비탄세스퀴올레이트 | 2.5 | 2.5 | 2.5 |
스쿠알란 | 3.0 | 3.0 | 3.0 |
유동파라핀 | 10.0 | 10.0 | 10.0 |
트리에탄올아민 | 0.5 | 0.5 | 0.5 |
토코페릴아세테이트 | 0.1 | 0.1 | 0.1 |
향료, 방부제 | 미량 | 미량 | 미량 |
정제수 | to 100 | to 100 | to 100 |
평균주름거칠기(Rz, ㎛) | |||||||||
실시예 | 비교실시예 1 | 비교실시예 2 | |||||||
T0 | T8 | ΔRz, | T0 | T8 | ΔRz, | T0 | T8 | ΔRz, | |
피검자 1 | 114 | 85 | -29 | 107 | 102 | -5 | 117 | 105 | -12 |
피검자 2 | 133 | 101 | -32 | 118 | 103 | -15 | 124 | 112 | -12 |
피검자 3 | 138 | 102 | -36 | 126 | 112 | -14 | 129 | 109 | -20 |
피검자 4 | 125 | 94 | -31 | 120 | 115 | -5 | 133 | 123 | -10 |
피검자 5 | 130 | 98 | -32 | 135 | 108 | -27 | 127 | 109 | -18 |
피검자 6 | 116 | 85 | -31 | 127 | 109 | -18 | 124 | 112 | -12 |
피검자 7 | 142 | 113 | -29 | 133 | 130 | -3 | 127 | 117 | -10 |
피검자 8 | 128 | 97 | -31 | 119 | 111 | -8 | 119 | 103 | -16 |
피검자 9 | 135 | 105 | -30 | 120 | 108 | -12 | 121 | 107 | -14 |
피검자 10 | 105 | 74 | -31 | 99 | 77 | -22 | 109 | 98 | -11 |
평균 | -31.2 | -12.9 | -13.5 |
평균주름거칠기(Rz, ㎛) | |||||||||
실시예 | 비교실시예 1 | 비교실시예 2 | |||||||
T0 | T8 | ΔRz, | T0 | T8 | ΔRz, | T0 | T8 | ΔRz, | |
피검자 1 | 114 | 73 | -41 | 107 | 98 | -9 | 117 | 100 | -17 |
피검자 2 | 133 | 89 | -44 | 118 | 94 | -24 | 124 | 105 | -19 |
피검자 3 | 138 | 90 | -48 | 126 | 102 | -24 | 129 | 104 | -25 |
피검자 4 | 125 | 82 | -43 | 120 | 105 | -15 | 133 | 100 | -33 |
피검자 5 | 130 | 89 | -41 | 135 | 102 | -33 | 127 | 99 | -28 |
피검자 6 | 116 | 77 | -39 | 127 | 99 | -28 | 124 | 107 | -17 |
피검자 7 | 142 | 97 | -45 | 133 | 120 | -13 | 127 | 112 | -15 |
피검자 8 | 128 | 87 | -41 | 119 | 101 | -18 | 119 | 99 | -20 |
피검자 9 | 135 | 96 | -39 | 120 | 100 | -20 | 121 | 101 | -20 |
피검자 10 | 105 | 55 | -50 | 99 | 75 | -24 | 109 | 90 | -19 |
평균 | -43.1 | -20.8 | -21.3 |
피부주름 개선 정도(ΔW) | |||||||||
실시예 | 비교실시예 1 | 비교실시예 2 | |||||||
T0 | T8 | T24 | T0 | T8 | T24 | T0 | T8 | T24 | |
피검자 1 | 0 | 2 | 3 | 0 | 0 | 1 | 0 | 1 | 1 |
피검자 2 | 0 | 2 | 2 | 0 | 1 | 2 | 0 | 1 | 2 |
피검자 3 | 0 | 1 | 2 | 0 | 1 | 2 | 0 | 1 | 2 |
피검자 4 | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 1 | 2 |
피검자 5 | 0 | 2 | 3 | 0 | 1 | 1 | 0 | 2 | 3 |
피검자 6 | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 1 |
피검자 7 | 0 | 2 | 3 | 0 | 2 | 3 | 0 | 1 | 2 |
피검자 8 | 0 | 2 | 3 | 0 | 1 | 2 | 0 | 2 | 2 |
피검자 9 | 0 | 1 | 3 | 0 | 1 | 1 | 0 | 1 | 2 |
피검자 10 | 0 | 3 | 3 | 0 | 2 | 3 | 0 | 1 | 1 |
ΔW(T-T0) | 1.7 | 2.6 | 0.9 | 1.7 | 1.1 | 1.8 |
피부주름 개선 정도(ΔW) | |||||||||
실시예 | 비교실시예 1 | 비교실시예 2 | |||||||
T0 | T8 | T24 | T0 | T8 | T24 | T0 | T8 | T24 | |
피검자 1 | 0 | 1 | 3 | 0 | 0 | 1 | 0 | 1 | 2 |
피검자 2 | 0 | 2 | 3 | 0 | 1 | 2 | 0 | 1 | 2 |
피검자 3 | 0 | 1 | 2 | 0 | 1 | 2 | 0 | 1 | 3 |
피검자 4 | 0 | 2 | 3 | 0 | 1 | 2 | 0 | 1 | 2 |
피검자 5 | 0 | 2 | 3 | 0 | 1 | 3 | 0 | 2 | 3 |
피검자 6 | 0 | 1 | 3 | 0 | 0 | 1 | 0 | 1 | 2 |
피검자 7 | 0 | 1 | 3 | 0 | 2 | 3 | 0 | 1 | 3 |
피검자 8 | 0 | 3 | 4 | 0 | 1 | 3 | 0 | 2 | 3 |
피검자 9 | 0 | 2 | 3 | 0 | 1 | 2 | 0 | 1 | 3 |
피검자 10 | 0 | 3 | 4 | 0 | 2 | 3 | 0 | 1 | 2 |
ΔW(T-T0) | 1.8 | 3.1 | 1.0 | 2.2 | 1.2 | 2.5 |
실험 제품 | 피부탄력효과 |
실시예 | 0.30 |
비교실시예 1 | 0.08 |
비교실시예 2 | 0.09 |
실험제품 | △TEWL (g/hm2) | 전도도 |
실시예 | 5.5 | 122 |
비교실시예 1 | 1.5 | 102 |
기호 | 판 정 기 준 | 평가 | 평균 |
± | 의심적 반응 또는 미소 반응 및 홍반(Doubtful or slight reaction and erythema) | 미소자극 | 0-0.9 |
+ | 홍반 + 경변 (Induration) | 경자극 | 1.0-2.9 |
++ | 홍반 + 경변 + 소포(Vesicle) | 중자극 | 3.0-4.9 |
+++ | 홍반 + 경변 + 수포(Bullae) | 강자극 | 5.0 이상 |
- | 무반응 (Negative) | 무자극 | 0 |
경과 시간 | 실시예 | 비교실시예 1 |
24시간 | 0 | 0.5 |
48시간 | 0 | 0.5 |
72시간 | 0 | 0 |
온도 | 변색 정도 | |
실시예 | 비교 실시예 1 | |
45℃ | 0 | 2 |
4℃ | 0 | 0 |
성분 | 함량 (중량%) |
빈랑자 추출물 | 0.1 |
글리세린 | 3.0 |
비타민 C | 0.05 |
부틸렌 글리콜 | 2.0 |
프로필렌 글리콜 | 2.0 |
카르복시비닐폴리머 | 0.1 |
에탄올 | 10.0 |
트리에탄올아민 | 0.1 |
방부제 | 0.3 |
향료 | 0.1 |
정제수 | to 100 |
성분 | 함량 (중량%) |
빈랑자 추출물 | 0.1 |
비타민 C | 1.0 |
밀납 | 4.0 |
폴리솔베이트 60 | 1.5 |
솔비탄세스퀴올레이트 | 0.5 |
유동파라핀 | 5.0 |
스쿠알란 | 5.0 |
카프릴릭/카프릭트리글리세라이드 | 5.0 |
글리세린 | 3.0 |
부틸렌글리콜 | 3.0 |
프로필렌글리콜 | 3.0 |
카르복시비닐폴리머 | 0.1 |
트리에탄올아민 | 0.2 |
방부제 | 0.3 |
폴리솔베이스 60 | 1.5 |
솔비탄세스퀴올레이트 | 1.0 |
유동파리핀 | 5.0 |
스쿠알란 | 3.0 |
마카다미아너트오일 | 2.0 |
향료 | 0.1 |
정제수 | to 100 |
성분 | 함량 (중량%) |
빈랑자 추출물 | 0.1 |
비타민 C | 3.0 |
밀납 | 10.0 |
폴리솔베이트 60 | 1.5 |
솔비탄세스퀴올레이트 | 1.0 |
유동파라핀 | 10.0 |
스쿠알란 | 5.0 |
카프릴릭/카프릭트리글리세라이드 | 5.0 |
글리세린 | 5.0 |
부틸렌글리콜 | 3.0 |
프로필렌글리콜 | 3.0 |
트리에탄올아민 | 0.2 |
방부제 | 0.3 |
카르복실비닐폴리머 | 0.5 |
향료 | 0.1 |
정제수 | to 100 |
성분 | 함량 (중량%) |
빈랑자 추출물 | 0.1 |
비타민 C | 3.0 |
밀납 | 10.0 |
폴리솔베이트 60 | 1.5 |
솔비탄세스퀴올레이트 | 0.8 |
유동파라핀 | 40.0 |
스쿠알란 | 5.0 |
카프릴릭/카프릭트리글리세라이드 | 4.0 |
글리세린 | 5.0 |
부틸렌글리콜 | 3.0 |
프로필렌글리콜 | 3.0 |
트리에탄올아민 | 0.2 |
방부제 | 0.3 |
카르복시비닐폴리머 | 0.5 |
향료 | 0.1 |
정제수 | to 100 |
성분 | 함량 (중량%) |
빈랑자 추출물 | 0.1 |
비타민 C | 3.0 |
폴리비닐알콜 | 13.0 |
소듐카르복시메틸셀룰로스 | 0.2 |
알란토인 | 0.1 |
에탄올 | 5.0 |
노닐페닐에테르 | 0.3 |
방부제 | 0.3 |
피이지-40 히드로게비이티드 캐스터오일 | 0.8 |
향료 | 0.1 |
정제수 | to 100 |
성분 | 함량 (중량%) |
빈랑자 추출물 | 0.1 |
비타민 C | 1.0 |
밀납 | 2.0 |
사이크로메치콘 | 2.0 |
유동파라핀 | 5.0 |
스쿠알란 | 5.0 |
스테아린산 | 2.0 |
카프릴릭/카프릭트리글리세라이드 | 4.0 |
글리세린 | 4.0 |
프로필렌글리콜 | 3.0 |
부틸렌글리콜 | 3.0 |
트리에탄올아민 | 1.0 |
알루미늄마그네슘실리케이트 | 0.5 |
안료 | 12 |
방부제 | 0.3 |
색소 | 3.0 |
향료 | 0.2 |
정제수 | to 100 |
Claims (7)
- (a) 비타민 C 또는 그 유도체, 그리고 (b) 빈랑자 추출물을 유효 성분으로 포함하는 피부 노화 방지용 화장료 조성물.
- 제 1 항에 있어서, 상기 비타민 C 유도체는 에틸 아스코빌 에테르, 마그네슘 아스코빌 포스페이트, 아스코브산 2-글루코사이드 또는 알란토인 아스코베이트인 것을 특징으로 하는 피부 노화 방지용 화장료 조성물.
- 제 1 항에 있어서, 상기 빈랑자 추출물의 양은 전체 화장료 조성물에 대하여 0.0001-10.0 중량%인 것을 특징으로 하는 피부 노화 방지용 화장료 조성물.
- 제 3 항에 있어서, 상기 빈랑자 추출물의 양은 전체 화장료 조성물에 대하여 0.001-10.0 중량%인 것을 특징으로 하는 피부 노화 방지용 화장료 조성물.
- 제 1 항에 있어서, 상기 비타민 C 또는 그 유도체의 양은 전체 화장료 조성물에 대하여 0.005-20 중량%인 것을 특징으로 하는 피부 노화 방지용 화장료 조성물.
- 제 1 항에 있어서, 상기 비타민 C 또는 그 유도체의 양은 전체 화장료 조성물에 대하여 0.05-10 중량%인 것을 특징으로 하는 피부 노화 방지용 화장료 조성물.
- 제 1 항에 있어서, 상기 주름개선 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 제형을 갖는 것을 특징으로 하는 피부 노화 방지용 화장료 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0074658A KR100468434B1 (ko) | 2001-11-28 | 2001-11-28 | 비타민 c 또는 그 유도체 및 빈랑자 추출물을 함유하는피부 노화 방지용 화장료 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0074658A KR100468434B1 (ko) | 2001-11-28 | 2001-11-28 | 비타민 c 또는 그 유도체 및 빈랑자 추출물을 함유하는피부 노화 방지용 화장료 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030043471A true KR20030043471A (ko) | 2003-06-02 |
KR100468434B1 KR100468434B1 (ko) | 2005-01-27 |
Family
ID=29571867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0074658A Expired - Fee Related KR100468434B1 (ko) | 2001-11-28 | 2001-11-28 | 비타민 c 또는 그 유도체 및 빈랑자 추출물을 함유하는피부 노화 방지용 화장료 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100468434B1 (ko) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR200452013Y1 (ko) * | 2010-11-17 | 2011-01-26 | 주식회사 소노코리아 | 진열장용 광고판 |
WO2017071822A1 (en) * | 2015-10-30 | 2017-05-04 | The Boots Company Plc | Skin care composition and method thereof |
WO2018001570A1 (en) * | 2016-06-30 | 2018-01-04 | The Boots Company Plc | Method of skin care |
WO2018001571A1 (en) * | 2016-06-30 | 2018-01-04 | The Boots Company Plc | Skin care composition and method thereof |
KR20210034832A (ko) * | 2019-09-23 | 2021-03-31 | 주식회사 코리아나화장품 | 병아리난초와 씀바귀의 혼합 추출물을 함유하는 비타민 c에 의한 피부자극 완화용 화장료 조성물 |
KR20230077990A (ko) * | 2021-11-26 | 2023-06-02 | 주식회사 코리아나화장품 | 소루쟁이와 승마의 혼합 추출물을 함유하는 비타민 c에 의한 피부자극 완화용 화장료 조성물 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160070892A (ko) | 2014-12-10 | 2016-06-21 | 코스맥스 주식회사 | 빈랑자(Areca catechu NUTS) 및 초두구(Aplinia katsumadai Hayata SEEDS) 혼합 추출물을 유효성분으로 함유하는 피부노화 예방 또는 개선용 화장료 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05320037A (ja) * | 1992-05-20 | 1993-12-03 | Tsuneo Nanba | 抗酸化剤 |
JPH05320063A (ja) * | 1992-05-20 | 1993-12-03 | Tsuneo Nanba | 活性酸素抑制剤 |
KR100457689B1 (ko) * | 1997-12-30 | 2005-05-17 | 주식회사 코리아나화장품 | 빈랑자추출물을함유하는화장료조성물 |
KR100604068B1 (ko) * | 1999-09-14 | 2006-07-24 | 주식회사 엘지생활건강 | 자유라디칼 소거제 혹은 항산화제로서 폴리에톡실레이티드 비타민 씨 유도체를 함유하는 조성물 |
KR20010058419A (ko) * | 1999-12-11 | 2001-07-06 | 유상옥,송운한 | 빈랑자 추출물을 함유하는 자유 라디칼 소거 화장료 조성물 |
KR100424728B1 (ko) * | 2001-05-28 | 2004-03-30 | 주식회사 바이오랜드 | 빈랑자 추출물과 알부틴을 함유하는 미백 및 주름개선기능성 화장료 조성물 |
KR20010088633A (ko) * | 2001-08-14 | 2001-09-28 | 김진경 | 비타민c를 혼합한 향액의 이용 방법 |
-
2001
- 2001-11-28 KR KR10-2001-0074658A patent/KR100468434B1/ko not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR200452013Y1 (ko) * | 2010-11-17 | 2011-01-26 | 주식회사 소노코리아 | 진열장용 광고판 |
WO2017071822A1 (en) * | 2015-10-30 | 2017-05-04 | The Boots Company Plc | Skin care composition and method thereof |
WO2018001570A1 (en) * | 2016-06-30 | 2018-01-04 | The Boots Company Plc | Method of skin care |
WO2018001571A1 (en) * | 2016-06-30 | 2018-01-04 | The Boots Company Plc | Skin care composition and method thereof |
CN109414601A (zh) * | 2016-06-30 | 2019-03-01 | 博姿有限公司 | 皮肤护理方法 |
AU2017290394B2 (en) * | 2016-06-30 | 2019-10-31 | The Boots Company Plc | Method of skin care |
KR20210034832A (ko) * | 2019-09-23 | 2021-03-31 | 주식회사 코리아나화장품 | 병아리난초와 씀바귀의 혼합 추출물을 함유하는 비타민 c에 의한 피부자극 완화용 화장료 조성물 |
KR20230077990A (ko) * | 2021-11-26 | 2023-06-02 | 주식회사 코리아나화장품 | 소루쟁이와 승마의 혼합 추출물을 함유하는 비타민 c에 의한 피부자극 완화용 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR100468434B1 (ko) | 2005-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4025546B2 (ja) | 美肌剤、皮膚の抗老化剤、美白剤および皮膚外用剤 | |
KR101393007B1 (ko) | 람부탄 및 리치 추출물을 유효성분으로 함유하는 피부노화방지용 및 피부주름 개선용 화장료 조성물 | |
JP2001163794A (ja) | ヒアルロン酸産生促進剤および皮膚外用剤 | |
WO2012002730A2 (ko) | 봉독 추출물을 함유하는 피부 미백 및 보습용 조성물 | |
JP2000128765A (ja) | 皮膚化粧料 | |
KR100468434B1 (ko) | 비타민 c 또는 그 유도체 및 빈랑자 추출물을 함유하는피부 노화 방지용 화장료 조성물 | |
KR102525579B1 (ko) | 쌀, 갈대, 옥촉서예, 당아욱 및 알로에추출물을 포함하는 피부 보호용 화장료 조성물 | |
KR100530669B1 (ko) | 락테이트 및 감초 추출물을 포함하는 피부 미백용 화장료조성물 | |
KR102044935B1 (ko) | 병아리콩 추출물을 포함하는 피부 미백용 또는 피부 보습용 화장료 조성물 | |
KR20110087363A (ko) | 멸가치 추출물을 유효 성분으로 포함하는 화장료 조성물 | |
JP2002370962A (ja) | 美白用化粧料および皮膚老化防止・改善用化粧料 | |
JP2000256175A (ja) | 化粧料組成物 | |
KR100678864B1 (ko) | 천궁 추출물 및 카르니틴을 유효성분으로 함유하는 피부미백용 화장료 조성물 | |
KR100604085B1 (ko) | 상지 추출물과 글루타치온을 함유하는 미백 화장료 조성물 | |
KR101317433B1 (ko) | 지구자, 길경, 밀싹 및 세이지 추출물을 함유하는 미백 화장용 조성물 | |
KR20070111025A (ko) | 녹두 추출물을 유효 성분으로 함유하는 피부 주름 개선용화장료 조성물 | |
KR100558184B1 (ko) | 미인초 추출물을 포함하는 화장료 조성물 | |
KR20220026746A (ko) | 모과, 감나무잎, 육계나무껍질, 쑥잎, 크리산텔룸인디쿰 및 녹차의 혼합추출물을 유효성분으로 함유하는 피부 보습용 화장료 조성물 | |
KR100424726B1 (ko) | 안정화시킨 비타민 c와 파이토스핑고신을 함유하는 피부보호화장료 조성물 | |
JP2702860B2 (ja) | 皮膚化粧料 | |
KR20170133617A (ko) | 비타민 c 또는 그 유도체와 빈랑자 분획물을 함유하는 피부 노화 방지용 화장료 조성물 | |
KR100415430B1 (ko) | 안정화시킨 l-아스코르브산을 함유하는 화장료 조성물 | |
KR100744947B1 (ko) | 천궁 추출물 및 프로테아제를 유효성분으로 함유하는 피부미백용 화장료 조성물 | |
JP7680990B2 (ja) | 肌のくすみ改善剤 | |
KR20130034720A (ko) | 아왜나무 추출물을 유효성분으로 함유하는 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20011128 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20031128 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20041229 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20050119 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20050119 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20080104 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20081208 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20091224 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20100902 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20110916 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20110916 Start annual number: 8 End annual number: 8 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |